Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
CartiHeal
CartiHeal is a medical device company that manufactures products for repairing articular cartilage and osteochondral defects.
Sector
Subsector
Keywords
Location
total rounds
total raised
Magneto Thrombectomy
This company develops a thrombectomy device for the treatment of ischemic stroke.
Sector
Subsector
Keywords
Location
total rounds
total raised
Orteq
Orteq is a medical device company that develops and commercializes bioengineering solutions for orthopaedic injuries.
Sector
Subsector
Location
total rounds
total raised
RapidPulse
RapidPulse develops minimally invasive vascular products for ischemic stroke.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 23.06.2014. Their latest investor Life Sciences Angel Network. Their latest round Venture - Series Unknown
Asset Management Ventures (AMV)
AMV is a venture capital firm that invests in early-stage digital health, tech, and life sciences companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Troika Dialog
Troika Dialog is a private investment bank specializing in capital markets.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors6
Number of lead investors
Number of investors
Life Sciences Angel Network
Life Sciences Angel Network provides early-stage life science companies with operational, mentorship and financial support.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Asset Management Ventures (AMV)
AMV is a venture capital firm that invests in early-stage digital health, tech, and life sciences companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Emergent Medical Partners
Emergent Medical Partners is a venture capital firm that focuses on investing in early-stage medical device and healthcare companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders3
Eric J. Kim
Eric Kim was a Managing Director with Maverick Capital where he focused on the Firm’s private investments globally and led a number of investments in technology-based companies. Prior to joining Maverick, Eric co-founded Biomimedia and also worked in the US and Asia as a member of McKinsey & Company’s global strategy practice focusing on M&A, technology licensing, turnaround strategies and new product launches. Eric received his MBA from Stanford’s Graduate School of Business and his Bachelors Degree in Cognitive Science from Yale University (Magna Cum Laude), where he was elected to Phi Beta Kappa and was a recipient of the Richard U. Light Fellowship.
current job
Eric J. Kim
David Myung
Dr. David Myung, MD, PhD, is an Assistant Professor of Ophthalmology at the Byers Eye Institute at Stanford and the VA Palo Alto Health Care System, where he serves as an attending physician and cataract surgeon. He is Co-Director of the Ophthalmic Innovation Program, a project-based fellowship in the development and regulatory science of new eye care technologies, and the Director of Ophthalmologic Telemedicine. Dr. Myung leads a translational research laboratory focused on two areas of clinical need: (1) ophthalmic regenerative medicine through tissue engineering and drug delivery, and (2) global health through mobile technologies and telemedicine. His research group takes an interdisciplinary approach toward fostering regeneration of ocular tissues, by using chemistry to not only build biomimetic cellular architectures but also to target and release bioactive molecules to promote healing. Current projects are directed toward the localized delivery of growth factors and/or stem cells to wound sites, the synthesis of bioactive wound dressings and vehicles, and the creation of biopolymeric tissue scaffolds. Dr. Myung and colleagues also investigate the role of mobile technologies in enabling diagnostics and patient care outside of traditional health care settings. His goal is to challenge current paradigms of eye care delivery through new digital health technologies to increase access to care in resource-limited settings both in the US and abroad.
current job
organization founded
David Myung